China BlueChemical Ltd. Reports 3% Decline in First-Half 2025 Revenue to RMB5.85 Billion; Net Profit at RMB641 Million

Reuters
09/29
China BlueChemical Ltd. Reports 3% Decline in First-Half 2025 Revenue to RMB5.85 Billion; Net Profit at RMB641 Million

China BlueChemical Ltd. reported its financial results for the six months ended 30 June 2025. The company recorded revenue of RMB 5.85 billion, compared to RMB 6.01 billion in the same period last year. Gross profit for the period was RMB 847.88 million, down from RMB 1.00 billion in the prior year. Net profit for the period was RMB 723.77 million, compared to RMB 743.37 million in the first half of 2024. Profit attributable to owners of the company was RMB 640.56 million, compared to RMB 686.83 million a year earlier. Basic and diluted earnings per share for the period were reported at RMB 0.14, compared to RMB 0.15 in the prior period. Finance income for the period was RMB 162.91 million, while finance costs totaled RMB 24.45 million. The company reported a net gain of RMB 83.72 million in other gains and losses, and a net exchange gain of RMB 0.82 million. Share of profits of joint ventures increased to RMB 61.03 million from RMB 3.04 million in the first half of 2024, while share of profits of associates was RMB 4.26 million, up from RMB 1.38 million a year ago. There were no significant updates regarding business operations included in the reported results.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. China BlueChemical Ltd. published the original content used to generate this news brief on September 29, 2025, and is solely responsible for the information contained therein.

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10